Share
Our Correspondent
Kohima, April 13 (EMN): A three-day programme for doctors, nurses and pharmacists on India Hypertension Control Initiative (IHCI) got underway at Directorate of Health and Family Welfare on Tuesday.
Dr. Ebenezer Phesao, medical officer of State Non-Communicable Disease (NCD) cell, gave a presentation on National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) in the state scenario during the programme.
NPCDCS programme, which was launched in 2010, was initially implemented in 100 districts but it has now being scaled up to cover almost all districts across the country.
While giving the timeline of NPCDCS in Nagaland, he said that it was initially launched in three districts -- Kohima District Hospital (DH), Dimapur DH and Tuensang DH. In 2018, it was launched in all the district hospitals.
The population based screening (PBS) started in two districts -- Kohima and Dimapur – before it was expanded to four districts (including Phek and Kiphire) in 2019, and then to all 11 districts in 2021.
The medical officer revealed that a total of 36417 persons were enrolled and 5586 screened in the state as of April 11, 2021. The district-wise breakup is: Kohima - 6762 enrolled, 3689 screened; Dimapur - 26,888 enrolled, 625 screened; Kiphire - 1671 enrolled, 774 screened; Phek - 669 enrolled, 117 screened; Wokha - 225 enrolled, 200 screened; Zunheboto - 137 enrolled, 121 screened; Peren - five enrolled, one screened; and Mon - 60 enrolled, 57 screened.
He also informed that a new initiative of IHCI had been adopted in Kohima and Mokokchung, while treatment protocol for hypertension was being adopted in Nagaland.
According to the World Health Organisation, NCDs collectively caused 41 million (71%) deaths worldwide. It also added that 80% NCD deaths occurred in low and middle income countries.
Consultant at ICMR-NIE Chennai, Dr. Mohamed Azarudeen gave an overview of India Hypertension Control Initiative (IHCI) which was launched in November, 2017 to strengthen the hypertension treatment component of the national program for NCD.